Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral vs Unilateral Botulinum Toxin A for Hemifacial Spasm
NCT03306940Unknown
- Sponsor
- Tongji University
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A in hemifacial spasm (HFS) (2 arms), sponsored by Tongji University. Primary endpoint: Sunnybrook Facial Grading System up to 6 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
hemifacial spasm (HFS)
Beyond the preview
Go deeper on NCT03306940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306940.